Pyrimidine Synthesis in IDH-Mutant Glioma: Identification of BAY 2402234 as a Novel Therapeutic Strategy

Pyrimidine Synthesis in IDH-Mutant Glioma: Identification of BAY 2402234 as a Novel Therapeutic Strategy

The Society for Neuro-Oncology is pleased to present the SNO Molecular Path Fast Webinar: Pyrimidine Synthesis in IDH-Mutant Glioma: Identification of BAY 2402234 as a Novel Therapeutic Strategy.

Please email academy@soc-neuro-onc.org for technical issues. 

Target Audience

Oncologists, Neuro-Oncologists, Neurosurgeons, Radiation Oncologists, Neurologists, Pathologists, Oncology and Neuro-oncology trainees, Oncology nurses and Nurse Practitioners. 

Speaker

Diana Shi
Children's Medical Center Research Institute at UT Southwestern
Harvard Radiation Oncology Program

Principal Investigator

Sam McBrayer
Children's Medical Center Research Institute at UT Southwestern

Molecular Pathology Special Interest Track Chairs:

Stephen Yip, MD, PhD
Vancouver General Hospital

Sandro Santagata, MD, PhD
Harvard Medical School

Jason Huse, MD, PhD
MD Anderson Cancer Center

SNO Board Representative for Neuropathology

Joanna Phillips, MD, PhD​
University of California San Francisco​